CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge

Molecules - Switzerland
doi 10.3390/molecules24071349
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Modern CRISPR/Cas9 Biotechnology Is a Current Challenge to Create Elite Disease Resistant Crops Cultivars

2019English

The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape

Viruses
VirologyInfectious Diseases
2019English

325. A Novel Utrophin-Based Genome Engineering Strategy for Duchenne Muscular Dystrophy Utilizing Recombinases and CRISPR/Cas9

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

CRISPR/Cas9: Prospects and Challenges

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2015English

What Is CRISPR/Cas9?

Archives of Disease in Childhood: Education and Practice Edition
Child HealthPediatricsPerinatology
2016English

CRISPR-Cas12 and Cas13: The Lesser Known Siblings of CRISPR-Cas9

Cell Biology and Toxicology
MutagenesisToxicologyHealthCell Biology
2019English

Development and Potential Applications of CRISPR-Cas9 Genome Editing Technology in Sarcoma

Cancer Letters
Cancer ResearchOncology
2016English

Targeting N-Terminal Huntingtin With a Dual-sgRNA Strategy by CRISPR/Cas9

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

RNA-guided Gene Activation by CRISPR-Cas9–based Transcription Factors

Nature Methods
BiochemistryBiotechnologyCell BiologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy